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Polycomb group (PcG) proteins are conserved
epigenetic transcriptional repressors that control
numerous developmental gene expression programs
and have recently been implicated in modulating
embryonic stem cell (ESC) fate. We identified the
PcG protein PCL2 (polycomb-like 2) in a genome-
wide screen for regulators of self-renewal and pluri-
potency andpredicted that it would play an important
role inmouse ESC-fate determination. Usingmultiple
biochemical strategies, we provide evidence that
PCL2 is a Polycomb Repressive Complex 2 (PRC2)-
associated protein in mouse ESCs. Knockdown of
Pcl2 in ESCs resulted in heightened self-renewal
characteristics, defects in differentiation, and altered
patterns of histone methylation. Integration of global
gene expression and promoter occupancy analyses
allowed us to identify PCL2 and PRC2 transcriptional
targets and draft regulatory networks. We describe
the role of PCL2 in both modulating transcription of
ESC self-renewal genes in undifferentiated ESCs
as well as developmental regulators during early
commitment and differentiation.
INTRODUCTION
Control over ESC-fate decisions is accomplished through
a variety of molecular, genetic, and epigenetic events. Exoge-
nous control of cell fate can be achieved by a limited number
of factors. When grown in fetal bovine serum (FBS)-containing
medium and in the presence of murine embryonic fibroblast
feeder cells (Evans and Kaufman, 1981; Martin, 1981) or the
cytokine leukemia inhibitory factor (LIF) (Smith et al., 1988; SmithCand Hooper, 1987; Williams et al., 1988), mouse ESCs remain
undifferentiated. BMP4, provided by the serum, functions in
the presence of LIF to maintain pluripotency by inducing phos-
phorylation and nuclear localization of Smad1, followed by upre-
gulation of Id proteins that block neural differentiation (Ying et al.,
2003a).
Three transcription factors are known to be critical in the
establishment and/or maintenance of ESC pluripotency. OCT4
(Pou5f1) has a highly conserved role in maintaining pluripotent
cell populations (Morrison and Brickman, 2006; Nichols et al.,
1998), and its expression level dictates ESC fate (Niwa et al.,
2000). SOX2 forms a complex with OCT4 and is necessary to
cooperatively activate target genes (Ambrosetti et al., 1997;
Yuan et al., 1995). NANOG is critical for initiating pluripotency
and maintaining OCT4 levels, even in the absence of LIF (Cham-
bers et al., 2003; Chambers et al., 2007; Mitsui et al., 2003), while
it is itself regulated by OCT4 and SOX2 (Rodda et al., 2005).
The polycomb group (PcG) proteins, first described in
D. melanogaster, regulate epigenetic states and are required
for proper repression of homeotic genes during development
(Schuettengruber et al., 2007; Schwartz and Pirrotta, 2007).
PcG proteins have been identified in either the PRC1 or the
PRC2 multiprotein complex (Lund and van Lohuizen, 2004).
The core components of PRC2 in Drosophila are Extra Sex
Combs, E(Z), and SU(Z)12. These proteins are found in distinct
complexes with additional accessory proteins that undergo
dynamic changes during development (Furuyama et al., 2003;
Kuzmichev et al., 2005). Core PRC2 members are highly con-
served between species (Schuettengruber et al., 2007), and their
mouse orthologs are EED, EZH2, and SUZ12, respectively (Cao
et al., 2002; Czermin et al., 2002). Through the methyltransferase
activity of EZH2, PRC2 induces gene repression by trimethylat-
ing lysine 27 on histone 3 (3meH3K27) (Cao et al., 2002; Pasini
et al., 2004; Silva et al., 2003).
In Drosophila, PCL (polycomb-like) is present in a subset of
PRC2 complexes (O’Connell et al., 2001; Tie et al., 2003).
Evidence suggests that PCL is required to generate high levelsell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc. 153
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Figure 1. Downregulation of Pcl2 Leads to Enhanced Self-Renewal and Impaired Differentiation Capacity
(A) Microarray expression profile of Pcl2 throughout both –LIF and +RA monolayer differentiation of OCT4:eGFP R1 ESCs.
(B) PCL2 has three predicted isoforms.
(C) Relative expression of Pcl2 mRNA in control and shRNA knockdown clones. Data are presented as mean ± standard deviation of triplicate experiments.
(D) Relative expression of Oct4, Nanog, and Sox2 in three different Pcl2 shRNA knockdown clones compared to wild-type R1 and two mismatch controls as
determined by qPCR. Data are presented as mean ± standard deviation of triplicate experiments.
(E and F) OCT4 protein wasmeasured by quantitative immunofluorescence in 10,000 individual cells of three different Pcl2 shRNA knockdown clones over 72 hr in
both +LIF and LIF conditions. In (E), the distribution of OCT4 expression is illustrated in a histogram for one representative Pcl2 shRNA knockdown clone and
a mismatch control. The distribution is best modeled as a double-Gaussian (red curve) which is a compilation of the OCT4-negative population (green curve) and
the OCT4-positive population (blue curve). The vertical red line represents the threshold between OCT4 +ve and –ve populations, and the percentage of cells
above and below this threshold is reported. In (F), the percentage of cells that had lost OCT4 expression at each time point is reported. Error bars represent
the standard deviation of triplicate experiments.
(G and H) Three different Pcl2 shRNA knockdown clones, wild-type R1, and two mismatch controls were plated in +LIF, and the distribution of colonies on each
plate that were undifferentiated or fully differentiated were determined by morphology and alkaline phosphatase (ALP) expression. The results are an average of
three separate experiments, each performed in triplicate.
Cell Stem Cell
PCL2 Is Required for ESC Commitment
154 Cell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc.
Cell Stem Cell
PCL2 Is Required for ESC Commitmentof 3meH3K27 at some target genes. However, gene repression
and 3meH3K27 of many known PRC2 targets is not abolished
in the absence of PCL, suggesting that PRC2 can function inde-
pendently of PCL at many target genes (Nekrasov et al., 2007). In
contrast to other PRC2 members, the lack of PCL produces
a mild homeotic phenotype, specifically affecting target gene
expression in central nervous system and mesoderm tissues
(Duncan, 1982; O’Connell et al., 2001). PCL2 is a mammalian
ortholog of PCL, and defects reported in animal models of
Pcl2 deficiency are consistent with lack of PCL in Drosophila.
In G. gallus (Wang et al., 2004), Pcl2 regulates left-right axis
specification, and in X. laevis (Kitaguchi et al., 2001), central
nervous system gene expression is disrupted by the lack of
Pcl2. Finally, hypomorphic Pcl2 gene trap mice have pleiotropic
defects, including posterior transformation of axial skeleton,
stunted growth, hydrocephaly, hunchback, and incisor abnor-
malities (Wang et al., 2007).
Here, we investigated the role of PCL2 inmouse ESCs. Reduc-
tion of PCL2 resulted in heightened self-renewal characteristics
and inefficient differentiation to the three germ layers. PCL2 was
found to associate with the core PRC2 complex, and using chro-
matin immunoprecipitation (ChIP) coupled with massively
parallel DNA sequencing (ChIP-seq), we found that PCL2 is
highly enriched at many, but not all, locations of PRC2 enrich-
ment. Loss of PCL2 did not abolish global levels of 3meH3K27
but did result in decreased 3meH3K27 at specific targets and
altered patterns of 3meH3K27 during early commitment. Inte-
grating PCL2-PRC2 targets with the ESC self-renewal circuitry
revealed a key role for PCL2-PRC2 in limiting transcription of
ESC self-renewal genes in undifferentiated ESCs, as well as
controlling developmental regulators during commitment and
early differentiation.
RESULTS
Identification of Mammalian Pcl2
In a screen for regulators of ESC fate, we hypothesized that
networks critical for the stability of the ESC state would be
differentially regulated at the initiation of commitment (Walker
et al., 2007). Transcript levels of Mtf2 (metal response element
binding transcription factor 2) decreased during differentiation
(Figure 1A), and promoter occupancy data indicated that Mtf2
is bound by both OCT4 and NANOG (Loh et al., 2006). Further
inspection revealed that the protein product of Mtf2 is ortholo-
gous toDrosophila PCL. Both proteins contain a TUDOR domain
and two PHD zinc finger domains (Figure 1B), and MTF2 shares
73% and 88% similarity to the PCL ortholog, PCL2, studied in
X. laevis (Kitaguchi et al., 2001) and G. gallus (Wang et al.,
2004), respectively. The mouse and human MTF2 protein
sequences share 96% identity. Thus, we will refer to the
mammalian Mtf2 transcript as Pcl2. Mammals have two other
PCL orthologs, PHF1 and PHF19, which have 63% homology
with PCL2 among the conserved domains. Interestingly, expres-(I) Fluorescent images depict Pcl2 shRNA knockdown and mismatch control cells
EB differentiation. Differentiation experiment was performed in duplicate.
(J) EBs were formed in suspension and cultured for 25 days (left panel). After 25 da
panel).
Csion analysis of Pcl2 in mice shows that it is uniquely expressed
in undifferentiated ESCs and during early embryonic develop-
ment (Figure S1A available online).
Downregulation of Pcl2 Results in Enhanced
Self-Renewal of ESCs
To examine the function of Pcl2 in ESCs, endogenous Pcl2
expression was stably knocked down using short hairpin RNA
(shRNA) (Kunath et al., 2003). We designed three shRNA
sequences targeting different regions of the Pcl2 mRNA, as
well as a mismatch control sequence to rule out indirect effects.
OneshRNAsequence resulted in themost significant reduction in
Pcl2. Three of these clones, each exhibiting at least 70% knock-
down in Pcl2 transcript compared to the mismatch control and
wild-type R1 ESCs, were chosen for further analysis (Figure 1C)
and used in all subsequent experiments. However, stable clones
expressing the additional two shRNA sequences were analyzed
in many of the assays and showed similar results (data not
shown). We also confirmed that knockdown in Pcl2mRNA levels
resulted in reduced protein levels (Figures S2B and S2C).
To test the effect of Pcl2 depletion on ESC self-renewal, we
measured transcript levels of Oct4, Nanog, and Sox2 and found
that they were increased in Pcl2 knockdowns (Figure 1D) over
both wild-type and mismatch controls. Next, we performed
a high-content fluorescence imaging assay to examine OCT4
protein levels in single cells (Davey and Zandstra, 2006; Walker
et al., 2007). The OCT4 distribution is best estimated by a double
Gaussian curve, and a threshold delineating OCT4 +ve and ve
cells was calculated as the intersection of these two curves
(Davey and Zandstra, 2006). Results are reported as the
percentage of cells above and below this threshold. At 3 hours
after plating, the cells were viable and contained over 90%
OCT4-positive cells (Figure 1E). Cells were cultured under
multiple differentiative conditions to study the effects of known
self-renewal mediators LIF and BMP4. In all cases, Pcl2 knock-
downs maintained a larger OCT4 +ve population (Figures 1E
and 1F, BMP4; data not shown). However, the intensity of the
OCT4 +ve peak in knockdown cells was not increased compared
to the control (Figure 1E). Thus, individual cells did not overex-
press OCT4. Instead, a greater percentage of the population
was OCT4 +ve. This resulted in the appearance of overexpres-
sion in bulk analyses (Figures 1D and 4A) and highlights the
importance of single-cell analyses in distinguishing distinct cell
states within a heterogeneous population.
In clonogenic assays (Peerani et al., 2009; Zhang et al., 2006),
cultures were stained for alkaline phosphatase (ALP) activity and
colonies were stringently scored, with only colonies resembling
those in Figure 1G being counted as undifferentiated. Pcl2
knockdown cells formed undifferentiated colonies with much
greater efficiency than controls (Figure 1H). Collectively, these
results suggest that knockdown of Pcl2 promoted self-renewal
and maintained the undifferentiated state of ESCs during the
initial time points following the cue to differentiate.stained for smooth muscle actin, Nestin, alpha fetoprotein, or OCT4 following
ys, they were trypsinized, cultured in +LIF for 3 days, and stained for ALP (right
ell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc. 155
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Differentiation Capacity
To test the effect of Pcl2 on differentiation capacity, we per-
formed directed neuroectoderm differentiation (Ying et al.,
2003b) assays and found Pcl2 knockdown cells maintained
high levels of OCT4 with no observable expression of Nestin
within a 5 day period (data not shown). Next, we used embryoid
body (EB) formation to determine how the cells would respond
when stimulated to differentiate for a prolonged period.
Compared to controls, knockdown EBs remained rounded,
and in general, cells did not migrate outwards, nor did they
acquire a differentiated morphology. Based on immunostaining,
control EBs formed large areas of both smooth muscle actin
(SMA, mesoderm) and Nestin (neuroectoderm)-positive cells
while knockdown EBs formed very few differentiated cells
(Figure 1I). Furthermore, knockdown EBs did not form a-fetopro-
tein (endoderm)-positive cells and maintained high levels of
OCT4 expression throughout the cultures (Figure 1I). We also
tested whether expression of lineage-specific genes was disrup-
ted and found that although transcripts of some markers of
mesoderm and ectoderm were eventually expressed, their
expression was delayed (Figure S1B). We also observed that
endodermmarkers were expressed to different extents in knock-
downs compared to controls (Figure S1B).
To test whether knockdown EBs would eventually differentiate
after extended culture, EBs were grown in suspension for
25 days (Kaji et al., 2006). After 25 days, control cultures con-
sisted of cystic EBs (Figure 1J, top left) that, when plated on
gelatin, developed into cells of differentiated morphology that
did not exhibit ALP activity (Figure 1J, top right). In contrast,
knockdown EBs remained as small, tightly compacted groups
of cells (Figure 1J, bottom left) and retained the capacity to
form undifferentiated ALP +ve colonies (Figure 1J, bottom right).
These data suggest that Pcl2 is critically involved in early
commitment and differentiation. Knockdowns appeared unable
to progress to terminal differentiation of some cell types and
retained a population of self-renewing ESC-like cells.
Ectopic Expression of PCL2 Partially Rescues
Knockdown Phenotype
To verify that the phenotype observed was specific to the deple-
tion of Pcl2, we performed rescue experiments by ectopically
expressing Pcl2-IRES-bgeo with a doxycycline-inducible trans-
poson expression system (Woltjen et al., 2009). Clones express-
ing the transgene encoding the predominate ESC isoforms
(Figures S2A and S2B) were selected based on b-galactosidase
expression (Figure 2A), PCL2 protein levels (Figure 2B), and Pcl2
transcript (Figure 2C) following 72 hr of treatment with doxycy-
cline. In colony-forming assays, overexpression of PCL2 was
not sufficient to return the normal ratio of differentiated to undif-
ferentiated colonies in +LIF (Figures 2D and 2E). However, under
–LIF conditions, rescue clones regained the ability to differen-
tiate (Figure 2E) and contained a normal percentage of OCT4-
negative cells (Figure 2F). Finally, after long-term culture in
doxycycline, expression of ESC-specific genes Oct4, Sox2,
Nanog, Esrrb, and Tcl1 were decreased (Figure 2G). These data
demonstrate that following overexpression of Pcl2 in the knock-
down clones, cells recover the ability to downregulate the pluri-
potency network and differentiate.156 Cell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc.PCL2 Is a PRC2-Associated Protein
InDrosophila, PCL associates with PRC2 (O’Connell et al., 2001;
Savla et al., 2008); therefore, we examined whether murine PCL2
associated with the PRC2 complex. Gel filtration analysis
indicated that PCL2 is found in two chromatographically distinct
peaks: a large molecular mass peak that coeluted with SUZ12,
EZH2, and EED and a smaller peak, which may represent the
monomeric form of PCL2 or smaller subcomplexes. SUZ12
and EED were also detected in fractions corresponding to the
smaller PCL2 peak (Figure 3A). These associations were
confirmed by coimmunoprecipitation experiments (Figure 3B).
Previous reports have suggested that PCL2 does not directly
interact with EZH2 (O’Connell et al., 2001), which prompted
us to further substantiate its association with SUZ12 using a
nonbiased epitope-tagged SUZ12 system coupled to mass
spectrometry.
We purified SUZ12-associated proteins from a mouse ESC
line containing a 6xHis-3xFLAG tag (HF) targeted to the C
terminus of one allele of the Suz12 gene, which resulted in
expression of a full-length tagged SUZ12 protein (Singla et al.,
2010). SUZ12-associated proteins were then separated by
SDS-PAGE and stained with Coomassie blue to identify interact-
ing proteins (Figure 3C). Mass spectrometric analysis indicated
that the two prominent bands at approximately 100 and
55 kDa contained proteins SUZ12, EZH1, and EZH2 and
RBBP4, RBBP7, AEBP2, EED, and PCL2, respectively (Fig-
ure 3D). In addition to a number of previously known interactors
of the PRC2 complex including RBBP4, RBBP7, and AEBP2
(Figure 3D) (Kim et al., 2009; Kuzmichev et al., 2002), we identi-
fied 15 peptides of PCL2 (Table S1). Taken together, these data
demonstrate that PCL2 associates with the PRC2 complex in
mouse ESCs.
PCL2 Knockdown Disrupts Global 3meH3K27 during
Differentiation
The PRC2 complex is responsible for mediating gene repression
by trimethylating H3K27. Loss of the core members of PRC2
results in disruption of the complex and decreased global
3meH3K27. Reduction of PCL2 using shRNA led to moderately
increased levels of EZH2 (Figures 4A and 4C) and global
3meH3K27 (Figures 4A and 4D) in the undifferentiated state,
while levels of 1meH3K27were unchanged (Figure 4B). Following
LIF withdrawal, EZH2 initially declined, and by day 6, the control
cells comprised three distinct cell populations expressing
different levels of EZH2 (Figure 4C). In the knockdown cells,
EZH2 levels did not decrease during the first 4 days of LIF with-
drawal, and a small portion of cells displayed decreased EZH2
at day 6 (Figure 4C). 3meH3K27 levels decreased in both control
and knockdown cells immediately following differentiation.
Consistent with their undifferentiated state, the knockdown cells
had slightlymore 3meH3K27 during the first day of differentiation
but contained similar levels to the control cells by day 4 of
differentiation. At day 6, control cells consisted of two different
populations of cells displaying two low but distinct levels of
3meH3K27, whereas knockdown cells comprised a single popu-
lation (Figure 4D). These data revealPcl2 is dispensable for EZH2
expression and global 3meH3K27 in undifferentiated cells.
However, upon the withdrawal of LIF, levels of both EZH2 and
3meH3K27 decline below the levels of the control.
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Figure 2. Induced Expression of PCL2 Partially Rescues Knockdown Phenotype
(A) Two Pcl2 shRNA clones containing the doxycycline inducible Pcl2-IRES-bgeo expression cassette were stained for b-galactosidase expression before and
72 hr after addition of doxycycline to the media.
(B) By western analysis, PCL2 protein was increased in the two rescue clones following doxycycline induction.
(C) By qPCR analysis, Pcl2 transcript was increased following doxycycline induction. Data are presented as mean ± standard deviation of triplicate experiments.
(D and E) The rescue clones were plated in +LIF or LIF, with or without doxycycline, and the distribution of colonies on each plate that were undifferentiated or
fully differentiated were determined by morphology and alkaline phosphatase (ALP) expression. Data are presented as mean ± standard deviation of triplicate
experiments.
(F) The percentage of cells in the rescue clones that had lost OCT4 expression by 72 hr in both +LIF and –LIF, with or without doxycycline. Data are presented as
mean ± standard deviation of triplicate experiments.
(G) Relative transcript levels of ESC-specific, self-renewal genes before and after long-term culture of rescue clones in doxycycline. Expression levels are
reported as a percentage of expression in wild-type R1 cells. Data are presented as mean ± standard deviation of triplicate experiments.
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To determine which genes were deregulated as a result of Pcl2
knockdown, we performed expression microarray analysis.
2585 probes (1152 genes) (Table S2) were downregulated and
1715 probes (770 genes) (Table S2) were upregulated (Figure 5A)
based on a fold-change cutoff of 1.5 and p value less than 0.05.
Gene ontology (GO) analysis (Beissbarth and Speed, 2004) indi-Ccated that upregulated genes are involved in transcription, chro-
matin remodeling, cell cycle, and DNA repair (Figure 5B) and
included several key markers of undifferentiated ESCs. The
majority of downregulated genes are involved in development
and differentiation (Figure 5C).
To identify direct targets of PCL2, we performed ChIP-seq
using a commercial antibody directed toward PCL2. Theell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc. 157
AC D
B Figure 3. PCL2 is a PRC2-Associated
Protein
(A) Gel filtration chromatography of ESC nuclear
proteins indicating that PCL2, EED, and EZH2
coelute in the same fractions.
(B) Immunoblot analysis demonstrates that EZH2
and SUZ12 proteins are detected following IP with
aPCL2-specificantibody. In addition, PCL2protein
is present following IP with an EZH2 antibody.
(C) Coomassie blue-stained gel of affinity-purified
SUZ12 complex.
(D) Mass spectrometry results showing interaction
of PCL2 with Suz12-HF.
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PCL2 Is Required for ESC Commitmentantibody was first tested for specificity by overexpressing Pcl2 in
293T cells (Figure S2A), as well as in the knockdown studies
(Figures S2B and S2C). ChIP DNAwas sequenced using the Sol-
exa 1G platform, aligned to the mouse genome, and enrichment
analysis was performed as described previously (Johnson et al.,
2007), resulting in 3,847 enriched regions with a FDR of 0.3%
(Table S3). Our analyses revealed that 47%of targets werewithin
100 kb of a known transcriptional start site (TSS) (Figure 5D) and
34%, or 1597 targets, were within 2 kb of a known TSS (Fig-
ure 5E). Further, GO analysis found that targets were involvedA
C D
B
158 Cell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc.in processes such as development,
pattern specification, and differentiation
(Figure 5F).
PCL2 Binds a Subset of PRC2
Targets and Is Associated with
H3K27 Trimethylation at Those
Targets
We have shown that PCL2 associates
with PRC2; however, it is not clear
whether PCL2 is present at all PRC2target locations. To identify specific targets regulated by the
PCL2-PRC2 complex, we compared our ChIP-seq data to pub-
lished ChIP-seq data sets for PRC2 components EZH2 and
SUZ12 in mouse ESCs (Ku et al., 2008), as well as sites contain-
ing the histone modifications 3meH3K27 (catalyzed by PRC2)
and 3meH3K4. This bivalent epigenetic mark occupies the
promoters of developmental regulators in mouse ESCs (Bern-
stein et al., 2006; Ku et al., 2008). Finally, we incorporated the
ChIP-seq data set for PRC1 component RING1B. Targets posi-
tive for both PRC2 and PRC1 binding are evolutionarilyFigure 4. PCL2 Knockdown Disrupts
3meH3K27 during Differentiation
(A) Immunoblot analysis demonstrates levels of
OCT4, EZH2, and 3meH3K27 in Pcl2 shRNA
knockdown and mismatch control cells. a-tubulin
was used as a loading control.
(B) H3K27 monomethylation levels in control
versus knockdown.
(C and D) EZH2 (C) and 3me-H3K27 (D) protein
was measured in 10,000 individual cells over
6 days in LIF conditions. The distributions are
best modeled as multipeak Gaussians (red curve)
that are a compilation of the low population (green
curve), midpopulation (blue curve), and high popu-
lation (yellow curve).
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Figure 5. Genome-wide Assessment of PCL2 Targets
(A) Volcano plot of differentially expressed genes between Pcl2 shRNA knockdown cells and mismatch control cells cultured in +LIF. Vertical red line represents
a fold change of ± 1.5. Microarrays were performed in triplicate, and the horizontal red line represents a cut-off p value of 0.05.
(B and C) GO analysis of genes upregulated and downregulated in knockdown cells.
(D) Location of enriched DNA sequence bound by PCL2 as determined by ChIP-seq.
(E) Histogram illustrating the distribution of enriched sequences in relation to known TSS.
(F) GO analysis illustrating the biological function GO terms overrepresented among the genes that were enriched in the ChIP-seq experiment. Statistically over-
represented GO terms were determined by comparing the incidence of a GO term within the input gene list (observed, red bar) to the incidence of that GO term
among the entire mouse genome recorded in the MGI database (expected, yellow bar). Fisher’s exact test was used to determine a p value for each term.
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PCL2 Is Required for ESC Commitmentconserved and present on the majority of developmentally asso-
ciated PRC2 targets (Ku et al., 2008).
By integrating these ChIP-seq data sets, we established that
953 were highly enriched for PCL2, EZH2, and SUZ12, and
96% of these targets were enriched for the bivalent domain
(3meH3K27 + 3meH3K4) (Figure S3A and Table S3) and 65%
were bound by RING1B. A second class of 772 targets was
bound by EZH2 and SUZ12, but enrichment of PCL2 was below
the 3-fold cutoff threshold. Comparable to the PCL2-PRC2
targets, 94% of these targets were enriched for the bivalent
domain and 55% were bound by RING1B. The remaining
subsets consisted of fewer targets and were not as likely to
contain the bivalent domain or RING1B. Thus, PCL2 is highly
enriched in a subset of PRC2 targets, and these targets are likely
to be enriched for the bivalent domain as well as RING1B.
Figure 6A shows the aligned occupancy results of 14 genes
whose expression was deregulated in the Pcl2 knockdowns.
Oct4, Nanog, and Tcl1 were not bound by PCL2, or any of the
PRC2 members, but were upregulated in the knockdowns.
These genes are highly expressed in ESCs, consistent with
exhibiting 3meH3K4, a well-validated transcriptional activation
mark, but not 3meH3K27. Thus, these genes are likely to be indi-
rectly inhibited by PCL2.
Tbx3 is also highly expressed in ESCs and was highly overex-
pressed in Pcl2 knockdowns. Consistent with this, Tbx3 exhibits
the activating 3meH3K4 modification. Interestingly, it is also
bound by PCL2, EZH2, and SUZ12 and has low levels of
3meH3K27. This suggests that Tbx3 is controlled by PCL2-
PRC2 through the modulation of 3meH3K27.
The remaining ten targets are developmental genes that were
regulated in the Pcl2 knockdowns. Overall, the binding profile of
PCL2 shows remarkable overlap with the profiles of the other
PRC2 members, strongly suggesting that they are binding to
the same region of DNA.
ChIP-qPCR with antibodies directed against each PRC2
component was performed on 14 targets. Additionally, ChIP-
qPCR was done on the knockdown cells to determine the effect
of PCL2 depletion on PRC2 occupancy and 3meH3K27 at
specific target promoters (Figures 6B–6F). 3meH3K27, as well
as all PRC2 members, were enriched at these 11 targets.
SUZ12 and EED enrichment were greatly reduced in the knock-
down cells (Figures 6C and 6D), and EZH2 appeared less
affected by loss of PCL2 (Figure 6E). Reduction in PCL2 expres-
sion does not disrupt the interactions of the core PRC2 compo-
nents (Figure S3B). Finally, despite our observation that global
3meH3K27 was not depleted by loss of PCL2, we observed
that 3meH3K27 enrichment was reduced by 2- to 3-fold in the
Pcl2 knockdown cells at these specific targets of PCL2
(Figure 6F). Collectively, these data are consistent with findings
in Drosophila (Nekrasov et al., 2007) and suggest that PCL2
promotes PRC2 function at specific target, and despite being
dispensable when assayed for global levels of 3meH3K27,
PCL2 is required at specific PCL2-PRC2 targets to achieve
proper 3meH3K27.
Our analysis also showed that PCL2 binds to a subset of
483 targets independently of PRC2. There is evidence that
PCL2 can act as an activating transcription factor in mouse
L-cells (Remondelli and Leone, 1997; Remondelli et al., 1997)
and, thus, may function independently of PRC2 at some targets.160 Cell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc.Upon further analysis, we found that most of these targets
showed weak PCL2 enrichment and were not regulated
following knockdown of Pcl2. Of the remaining 152 genes that
were both bound and regulated, we then carefully analyzed
the binding profiles of the other PRC2 members and found
that, despite being below the cutoff threshold in the EZH2 and
SUZ12 experiments, there was binding above background for
nearly all. Ultimately, we identified a subset of 23 targets that
appeared to be bound by PCL2 and not by other PRC2 proteins
and that were also regulated following Pcl2 knockdown. ChIP-
qPCR at 11 of these targets confirmed that PCL2 was weakly
bound in the wild-type cells and depleted in the knockdown
cells (Figure S3C). EZH2 and 3meH3K27 were absent at these
targets and were not altered following knockdown of Pcl2
(Figures S3D–S3F). However, binding patterns of SUZ12 were
remarkably similar to those of PCL2, and SUZ12 was displaced
from these targets following knockdown of Pcl2 (Figure S3D).
Enrichment of SUZ12 at some of these targets (Figure S3D)
suggests that they were false negatives in the SUZ12 ChIP-
seq experiment. Together, these data suggest that if PCL2
regulates these targets, it may do so in cooperation with
SUZ12 through a mechanism independent of 3meH3K27.
However, with the exception of Inhb1, regulation following
knockdown or overexpression is not significant (Figures S3H
and S3I), and these targets are not regulated following the with-
drawal of LIF (Figure S3H). It is possible that regulation of these
targets is not critical in undifferentiated ESCs. It remains
possible that PRC2 may play a role in regulating these targets
in alternate cell types.
Predicting and Testing PCL2-Dependent ESC
Regulatory Networks
To draft potential PCL2-PRC2-dependent ESC regulatory
networks, we combined our ChIP-seq and microarray expres-
sion data with published ChIP-PET experiments for OCT4 and
NANOG (Loh et al., 2006). The proximal promoter of Pcl2 is
bound by both OCT4 and NANOG, and because Pcl2 is downre-
gulated concomitantly with Oct4 and Nanog, we reason that
OCT4 and NANOG activate Pcl2. To extend the network, we
incorporated our previously published time-course microarray
data of differentiating ESCs (Walker et al., 2007). The complete
network of 953 PCL2-PRC2 targets is summarized in Figure S4
and reveals that there is substantial overlap between the targets
of OCT4, NANOG, and PCL2-PRC2. We found two distinct
classes of targets. First, in the case of ESC-specific genes,
OCT4 and NANOG exert an activating pressure that is opposed
by the repressive effect of PCL2-PRC2. The interaction of three
genes known to be important for ESC self-renewal (Tbx3, Klf4,
and Foxd3) is highlighted in Figure 7A. The second class of
OCT4, NANOG, and PCL2-PRC2 targets comprise develop-
mental regulators that are directly repressed by PCL2-PRC2
(Figure 7B) but also repressed indirectly by OCT4 and NANOG
through the activation of the extended pluripotency network
(Figure S4).
To test the response of target genes immediately following
perturbation of Pcl2, we used both transient siRNA and inducible
overexpression. Pcl2 transcript was depleted by 90% at 24 hr
post-siRNA transfection, and target expression was elevated
compared to the siRNA control by 72 hr (Figure 7C). Conversely,
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Figure 6. PCL2 Binds a Subset of PRC2 Targets and Is Associated with 3meH3K27
(A) Binding profiles of 14 PCL2 and PRC2 targets. Genomic range in each panel extends 10 kb from the TSS to the end of the gene.
(B–F) ChIP-qPCR validation of 14 selected promoter regions in both wild-type and knockdown cells for PCL2, EZH2, EED, SUZ12, and 3meH3K27. Values are
calculated as the fold enrichment above a control without antibody. Wild-type versus knockdown samples were normalized to a fraction of the input material for
each primer set tested to adjust for differences in starting amounts. Error bars represent the standard deviation of duplicate DNA samples. ChIP experimentswere
repeated three times, and comparable results were obtained for each experiment.
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of Pcl2 and observed that targets were decreased 72 hr after
doxycycline treatment (Figure 7D).
In the case of the developmental genes, increased expression
following transient siRNA (Figure 7C) is in contrast to the reduced
expression of those same targets in the long-term culture of the
Pcl2 shRNA knockdown cells. We propose that this effect is dueCto increased repressive pressure on developmental targets
exerted by the pluripotency network, which is overexpressed
in the knockdown cells. Gene expression resulting from the
long-term depletion of Pcl2 is consistent with expression
patterns of developmental targets in Suz12 and Ezh2 null ESCs
(Pasini et al., 2007; Shen et al., 2008) (Figure 7E), although it is
most similar to Suz12 null cells.ell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc. 161
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Figure 7. Predicting PCL2-Dependent Regulatory Networks
(A) Identification of one networkmotif that functions tomodulate ESCpluripotency and self-renewal. Genes connected by an arrowwere activated by the initiating
gene, whereas genes connected by a T bar were repressed. Activation and repression is supported by promoter occupancy studies or microarray expression
changes following knockdown.
(B) Summary of the categories of developmental genes found to be targeted by the PCL2-PRC2 complex.
(C) A pool of Dharmacon siRNAs targeting the Pcl2 transcript were used to acutely knock down Pcl2. Cells were retransfected 48 hr after the first transfection to
maintain depletion of Pcl2. Relative expression of Pcl2, as well as a set of potential targets, were measured 24 and 72 hr following transfection, in both +LIF
and –LIF. Error bars represent the standard deviation of triplicate experiments.
(D) Pcl2 expression was induced in the rescue clones, and transcript levels of the potential targets were measured 72 hr after doxycycline induction. Transcript
levels are reported relative to their expression level in wild-type ESCs. Error bars represent the standard deviation of triplicate experiments.
(E) Microarray results from Pcl2 knockdowns and Suz12 and Ezh2 null cells.
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We predict that PCL2-PRC2 represses key members of the
pluripotency network (Figures 7A and 7C–7E). Cells of the inner
cell mass and ESCs, their in vitro derivatives, must undergo
self-renewal while remaining poised to differentiate in response
to extrinsic cues. Accumulated evidence suggests that ESCs
maintain self-renewal through the autoregulation of the pluripo-
tency TFs Oct4, Nanog and Sox2. In addition, some of the
primary targets of these TFs, such as Tbx3, Klf4 and Foxd3,
support the pluripotency phenotype in part by stabilizing Oct4,
Nanog, and Sox2 through feedback mechanisms (Hanna et al.,
2002; Ivanova et al., 2006; Kim et al., 2008). It has recently
been shown that overexpression of either Tbx3 or Klf4 can
support LIF-independent self-renewal (Niwa et al., 2009). Addi-
tionally, overexpression of Klf4 can be used to revert adult fibro-
blasts to a pluripotent state and convert EpiSCs to ESCs (Guo
et al., 2009; Takahashi and Yamanaka, 2006). Thus, it is likely
that overexpression of Tbx3 and Klf4 due to depletion of PCL2
is a major determinant of the Pcl2 knockdown phenotype, as
predicted in our draft network (Figure 7A). Such a self-reinforcing
network should result in a stable, self-renewing population of
pluripotent stem cells.
However, experience reveals that even when grown under
self-renewal culture conditions, a small but noticeable per-
centage of ESCs commit and undergo morphologically
distinguishable differentiation. Furthermore, upon removal of
LIF or induction of differentiation by addition of external signals
such as retinoic acid, wild-type ESCs are able to rapidly down-
regulate these genes in response to external signals. We
propose that PCL2 is critical for maintaining the capacity of
ESCs to commit rather than self-renew by exerting repressive
pressure on Tbx3, Foxd3, and Klf4 through a feed-forward
mechanism, thus dampening the autoregulatory network driving
self-renewal to the point the cells can respond to external inputs
(Figure 7A). Feed-forward motifs have been shown in bacteria to
accelerate target response time andmaintain steady-state levels
of the target (Alon, 2007), and stabilization of transcript levels of
Tbx3, Foxd3, and Klf4 and indirectly of Oct4, Nanog, and Sox2
through PCL2-PRC2 repression may be further beneficial to
ESCs because it allows activation by a strong promoter, without
risk of overshooting the optimal pluripotency TF concentration.
Thus, one potential function of PCL2-PRC2 repression of ESC-
specific genes is to allow rapid activation of the extended pluri-
potency network once the initiating TFs have been activated.
Another potential function of PCL2-PRC2 repression is to regu-
late ESC fate by interrupting the self-reinforcing network that
maintains pluripotency once the ESC is exposed to a differentia-
tive environment.
Genome-wide promoter occupancy studies in ESCs have
shown that EZH2, SUZ12, and EED also bind a large number
of TFs required for development, leading to the hypothesis that
PcG proteins maintain the ESC state by repressing develop-
mental regulators that would otherwise cause the cells to differ-
entiate (Boyer et al., 2006; Lee et al., 2006). However, knock-
down and knockout studies of PcG proteins in ESCs have not
supported this hypothesis. In the mouse, ablation of any of the
three core PRC2 components does not result in embryonic
lethality until the time of gastrulation (Faust et al., 1995; O’CarrollCet al., 2001; Pasini et al., 2004), and both Suz12 and Eed null
ESCs can be derived. Suz12 null ESCs maintain an undifferenti-
ated morphology and high levels of ESC markers even after
withdrawal of self-renewal signals and are unable to differentiate
into mature cell types (Pasini et al., 2007), which is similar to our
findings for Pcl2 knockdowns in ESCs. Additionally, Eed null
ESCs express heightened levels of differentiation genes but
also maintain high levels of ESC markers and can be taken to
high passage without losing their undifferentiated morphology
(Chamberlain et al., 2008). This suggests that PCL2-PRC2 and,
in general, PRC2 target repression are not required to maintain
the undifferentiated state. However, consistent with the estab-
lished role of PRC2 in Drosophila gastrulation (Schuettengruber
et al., 2007) and recent work implicating PcG in pattern formation
(Oktaba et al., 2008), PCL2 depletion most dramatically affected
PCL2-PRC2 target gene expression profiles during the early
stages of ESC commitment to differentiation.
Despite the observed effect of PCL2 in modulating 3meH3K27
and PRC2 levels at its target promoters, we found that the integ-
rity of the interactions between the core PRC2 components
could still be observed in cell lysates from Pcl2 knockdown cell
lines. This could suggest that PCL2 is involved in the recruitment
of the PRC2 complex, but not in its formation or stability.
It is counterintuitive to consider that Pcl2 is both highly
expressed in ESCs but required for repression of the self-
renewal circuitry. The emerging landscape of the self-renewal
regulatory network is of a dense and interconnected system of
autoregulatory and feedback loops (Kim et al., 2008). We
propose that one function of PCL2 is to provide the ESC with
a mechanism to hold this system in check. Repression of self-
renewal genes by Tcf3 represents one other such ESC regulatory
mechanism that has recently been identified (Yi et al., 2008). It
will also be interesting to determine whether depletion of PCL2
will enhance the ability of adult cells to be reprogrammed into
induced pluripotent stem cells (iPSCs). It is possible that the
forced downregulation of PCL2 could result in hyperactivation
of the self-renewal regulatory network, providing a selective
advantage for reprogrammed cells.
EXPERIMENTAL PROCEDURES
ESC Culture
R1 ESCs were cultured as described previously (Walker et al., 2007).
shRNA Vector Design, Construction, and Electroporation
Three independent shRNA sequences were designed, cloned, and electropo-
rated into R1 ESCs, and clones were derived as previously described (Walker
et al., 2007). Mismatch controls were created by altering five of the 21 bases in
the chosen Pcl2 shRNA sequence. Pcl2 target and mismatch sequences are
provided in Supplemental Experimental Procedures.
Immunoprecipitation
R1ESCswere pelleted and resuspended in co-IP lysis buffer. Twomicrograms
of antibody and 1 mg of total protein were combined, followed by immobiliza-
tion with protein A/G beads (Pierce). The sample was separated from beads by
centrifugation and run on a 15% SDS-PAGE for standard western blot anal-
ysis. Details of buffer solutions, antibody specifications, and western blot
procedure are provided in Supplemental Experimental Procedures.
Protein Quantification in Single Cells
Cells were plated, cultured, stained, and imaged as described previously
(Walker et al., 2007). Ten-thousand individual cells were imaged, andGaussianell Stem Cell 6, 153–166, February 5, 2010 ª2010 Elsevier Inc. 163
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details are provided in Supplemental Experimental Procedures.
Quantitative Real-Time PCR
Total RNA extraction and reverse transcription were performed as described
(Walker et al., 2007). Serial dilutions of mouse genomic DNA were used to
generate standard curves to adjust for the efficiency of each primer (Yun
et al., 2006). Mouse genomic DNA standards or the cDNA template were
added to the qPCR reaction in a final volume of 10 ml containing 2x SYBR
master mix (Roche) and 0.5 mM primers. Standard Roche PCR protocol was
performed on the Roche Light Cycler 480. qPCR primers are provided in
Supplemental Experimental Procedures.
Clonogenic Assay and ALP Staining
Single-cell suspensions were plated in a 12-well dish at a density of 500 cells/
well. Colonies were grown in +LIF for 5 days with media changed daily. ALP
staining was performed as described previously (Walker et al., 2007).
Microarray Hybridizations
Total RNA was extracted from Pcl2 mismatch controls and one Pcl2 shRNA
clone with RNeasy columns (QIAGEN). RNA quality was tested using an Agi-
lent Bioanalyzer before performing standard cDNA synthesis (Invitrogen
Superscript) and in vitro transcription (IVT) (Enzo IVT kit). Ten micrograms
of RNA was used for IVT, and 15 mg of cRNA was used for hybridization
(EukGE-WS2v4 kit) to the Mouse Genome 430 2.0 GeneChip. Scanning was
performed using the Affymetrix GeneChip Scanner 3000 and analysis done
using GCOS1.4 to obtain signal-log ratios of the control to the sample. Hybrid-
izations of three biological replicates for both the control andPcl2 shRNA clone
were performed.
ChIP-seq and ChIP-qPCR
DNA sonicated to approximately 1 kb lengths was supplied to The Centre for
Applied Genomics (TCAG) for high-throughput sequencing or used for qPCR.
Details of buffer solutions and qPCR primers are provided in Supplemental
Experimental Procedures.
Generation of the HF-Tagged Allele of Suz12
An allele of Suz12 encoding a full-length protein with a carboxy-terminal
3xFLAG-TEV-6xHis tag was created using a Cre recombinase-mediated
modification of a gene trap allele. Briefly, we obtained an ESC line with
a gene trap insertion in the seventh intron of the Suz12 locus (XG122, Bay
Genomics). Transient expression of Cre recombined Lox sites flanking the
splice acceptor, and Cre-mediated recombination was also used to subse-
quently insert the coding sequence of the nine 30 exons and tags.
Purification of Suz12-HF and Identification of Suz12-Interacting
Proteins by Mass Spectrometry
Suz12-HFwas purified according to the protocol of Andrew Krutchinsky (Deng
et al., 2009). Modifications are noted in the Supplemental Experimental Proce-
dures. After being separated by SDS-PAGE and stained with Coomassie blue
(GelCode Blue, Pierce), protein bands were excised and processed for diges-
tion with trypsin (Promega) as described (Shevchenko et al., 1996) and
analyzed by LCMS.
Gel Filtration Chromatography
Nuclear protein extract was prepared from undifferentiated mouse ESCs as
described by Dignam et al. (1983). Proteins (5 mg/ml) were separated by
AKTA FPLC using a Superose 6HR 10/30 gel filtration column (GEHealthcare).
Approximately 1 mg of protein was loaded onto the column in a 50 mM Phos-
phate buffer containing 0.015 M NaCl (pH 7.0). Proteins were eluted at a flow
rate of 0.4 ml/min in the same buffer, and 250 ml fractions were collected and
analyzed by western blotting.
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